The long hauler study has been green-lit by the FD
Post# of 148179
Doesn't mention leronlimab by name but we all know which mab they are talking about!
https://www.local10.com/news/local/2021/02/04...ssion=true
"Dr. Norman Gaylis, a South Florida rheumatologist, is among the first to begin enrolling patients in the study, which was just given the green light by the U.S. Food and Drug Administration."
"The double-blind study will compare a placebo versus a monoclonal antibody to see if the drug could have an impact on small proteins involved in the body’s immune response."